EHA2024 Chronic Lymphocytic Leukemia Preview: The Road Ahead With Targeted Therapies

Поділитися
Вставка
  • Опубліковано 10 чер 2024
  • Join the experts for an in-depth discussion on the latest developments in targeted therapies for relapsed/refractory chronic lymphocytic leukemia (R/R CLL), and a look ahead to the upcoming EHA2024 conference. Credit available for this activity expires: 6/6/2025 Earn Credit / Learning Objectives & Disclosures: www.medscape.org/viewarticle/...
  • Розваги

КОМЕНТАРІ •